Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
small portion of the tumor. Once the diagnosis is made, few criteria are available to predict treatment efficacy. Cancer therapies increasingly rely on biological and morphological criteria
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | about 2 months ago
of M. tuberculosis and the immune system, in order to find mechanisms associated with the slow progression of TB. These mechanisms will serve as the basis for the development of new immune therapies
-
development of therapies, such as RNAi, gene splicing modification, and dominant-negative inhibition of disease in animal models of prion disease. The Mastrianni Lab. https://voices.uchicago.edu/mastriannilab
-
-metabolism and neuroinflammation, particularly in the eye. The Tribble lab uses a bench-to-bedside approach to develop clinically translatable therapies for neurodegeneration including nutraceuticals and gene
-
groups include ERC grant awardees and tackle frontier topics in personalized medicine, advanced therapies, cancer/metastasis, ageing, and AI-driven tools for healthcare, among others. This innovative
-
provides a cellular therapy program, which includes the use of viral specific T-cells (VSTs), chimeric antigen receptor (CAR) engineered T-cells and gene therapy products. As a clinical fellow in our Bone
-
significantly in size, funding, and scope, contributing to advances in emerging fields such as stem cell biology, RNA interference, and gene therapy. The mission of the Department of Pharmacology is to: Educate
-
, innovative, and quality care for patients with heart conditions including coronary heart disease, heart valve disease (structural), heart failure (advanced cardiac therapies), heart rhythm disorders
-
subset of the neuromuscular division’s industry-sponsored drug trials. These may include gene therapies, small molecule drug trials, and other projects dealing with pediatric and adult neuromuscular
-
learn about RNA gene therapies and different aspects of its delivery. Third, you will be actively involved in projects that are intended for clinical translation. Finally, the University of British